Publications by authors named "A Tourbah"
Background: Venous sinus stenting (VSS) is an increasingly performed procedure for the treatment of idiopathic intracranial hypertension (IIH) refractory to medical treatment. VSS is typically performed under general anesthesia.
Objective: To present our experience of VSS in patients with IIH performed under conscious sedation.
Secondary progressive multiple sclerosis: A national consensus paper on diagnostic criteria.
Rev Neurol (Paris)
December 2022
Background: In clinical practice, the diagnosis of secondary progressive multiple sclerosis (SPMS) is often delayed, retrospective and non-reproducible, as there are no consensus criteria that define the advent of SPMS. Early identification of SPMS is essential to improve patient care.
Methods: Eight regional board meetings in France involving 56 multiple sclerosis (MS) experts (neurologists) were convened to discuss diagnostic criteria for SPMS.
Background: The perception of diagnosis announcement, the social support and the coping strategies seem to be determining factors for the quality of life of multiple sclerosis (MS) patients, with possible transcultural variations. This study explores these psychosocial dimensions in Lebanese and French MS patients.
Methods: For this cross-sectional multi-center study, 8 questionnaires were used to assess quality of life, family support, coping strategies, mood, fatigue, stress, and hopelessness in MS patients.
Article Synopsis
- Younger individuals, those with oligoclonal bands, and patients with specific brain and spinal cord lesions have a higher risk of developing multiple sclerosis (MS) from radiologically isolated syndrome (RIS) over a 10-year period.
- A study aimed to assess the 2-year risk of MS symptoms in people with RIS and identify factors influencing this risk, as well as determine the necessary sample size for future clinical trials.
- Out of 372 participants with RIS, 354 were analyzed, and 13.8% experienced a clinical event within 2 years, with a significant correlation to being younger than 37, indicating an estimated conversion risk of 19.2%.
Background: A previous clinical study showed the high specificity, sensitivity and reliability of MSCopilot, a software medical device designed by Ad Scientiam for the self-assessment of people with Multiple Sclerosis (PwMS), compared to the traditional Multiple Sclerosis Functional Composite (MSFC). We conducted further analyses to assess MSCopilot's performance with respect to the Expanded Disability Status Scale (EDSS).
Methods: The data of 116 PwMS were analysed.